Blinatumomab vs Dapagliflozin

## Blinatumomab vs Dapagliflozin: Overview

This comparison examines the pharmacological differences between **Blinatumomab** and **Dapagliflozin**.

## Mechanism of Action

**Dapagliflozin**: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

## Pharmacokinetics

**Half-life**: Blinatumomab — N/A; Dapagliflozin — 12.9 hours.

## Chemical Properties

**Molecular Formula**: Blinatumomab — N/A; Dapagliflozin — C21H25ClO6.

**Molecular Weight**: Blinatumomab — N/A; Dapagliflozin — 408.8730 g/mol.

**Type**: Blinatumomab — Antibody; Dapagliflozin — Small molecule.